EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Evaluation and Pregnancy Outcomes in Foetuses With Overgrowth at a Tertiary Referral Center

Xiaoqing Wu iD, Qingmei Shen, Xiaorui Xie, Yuqin Chen, Bin Liang, Meiying Wang, Danhua Guo, Na Lin, Liangpu Xu iD

Journal of Cellular and Molecular Medicine · 2026-07 · 30 (14)

DOI: 10.1111/jcmm.71162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 27.07.2026. Verfasst von Xiaoqing Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzho…. Hauptthemen laut MEDLINE: Pregnancy Outcome, Fetus. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Funds for the innovation of science and Technology, Fujian province (grant no. 2025Y9613), Fujian Provincial Health Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fetal overgrowth is defined as one or more biometric parameters exceeding the 90th–97th percentile or 2 standard deviations above the mean for gestational age. This study aimed to evaluate genetic findings in foetuses diagnosed with sonographic overgrowth. We retrospectively analysed 78 singleton pregnancies that underwent invasive prenatal diagnosis between 2018 and 2024. Fetal overgrowth was defined based on biparietal diameter (BPD), head circumference (HC), and/or abdominal circumference (AC), and cases were categorized into three groups according to the pattern of enlargement: head enlargement (Group A, n = 49), abdominal enlargement (Group B, n = 12), and combined head and abdominal enlargement (Group C, n = 17). All foetuses underwent conventional karyotyping and single nucleotide polymorphism array analysis, and were further classified as isolated or non‐isolated based on the presence of additional ultrasound findings. Chromosomal abnormalities were identified in 2 cases (2.6%) by karyotyping, including mosaic 47,XYY/45,X and 46,X,add(X)(p22)/45,X, while SNP array detected copy number variants involving chromosome 11 in 2 additional cases, one likely pathogenic and one variant of uncertain significance. Notably, all chromosomal abnormalities were observed in the non‐isolated overgrowth group. Overall, 12 cases (15.4%) were classified as isolated and 66 (84.6%) as non‐isolated. Associated ultrasound findings included structural anomalies in 18 cases, non‐structural abnormalities in 12 cases, soft markers in 28 cases, and multiple coexisting abnormalities in 20 cases. Ventriculomegaly was the most common structural anomaly, particularly among foetuses with head enlargement, while polyhydramnios was the most frequent non‐structural finding. Follow‐up data were available for 76 cases, with 8 pregnancies resulting in stillbirth or termination and 68 in live births. Foetuses with combined head and abdominal enlargement had a significantly higher incidence of macrosomia compared with those with isolated head or abdominal enlargement (29.4% vs. 4.3% and 8.3%, respectively; p = 0.015). In conclusion, fetal overgrowth is predominantly non‐isolated, and chromosomal abnormalities are mainly observed in this subgroup. Concurrent head and abdominal enlargement is associated with increased risks of structural anomalies and macrosomia. Prenatal genetic testing and macrosomia‐specific management should be considered for head‐abdominal enlargement foetuses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy OutcomeFetusHumansFemalePregnancyChromosome AberrationsTertiary Care CentersKaryotypingPolymorphism, Single NucleotideRetrospective StudiesAdultUltrasonography, Prenatal

Stichwörter der Autor:innen

biometric parameterschromosomal abnormalitieschromosomal microarray analysisfetal overgrowthkaryotyping

Autor:innen und Institutionen

  • Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.
  • Fujian Provincial Key Laboratory for Prenatal Diagnosis and Birth Defect, Fuzhou, Fujian, China.
  • Department of Laboratory Medicine, Fujian Medical University, Fuzhou, Fujian, China.
  • Key Laboratory of Clinical Laboratory Technology for Precision Medicine (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.

ORCID-Profile: Xiaoqing Wu, Liangpu Xu

Förderung

  • Joint Funds for the innovation of science and Technology, Fujian province (grant no. 2025Y9613)
  • Fujian Provincial Health Technology Project

Zitieren

APA

Wu, X., Shen, Q., Xie, X., Chen, Y., Liang, B., Wang, M., Guo, D., Lin, N., & Xu, L. (2026). Genetic Evaluation and Pregnancy Outcomes in Foetuses With Overgrowth at a Tertiary Referral Center. Journal of Cellular and Molecular Medicine, 30(14). https://doi.org/10.1111/jcmm.71162

Vancouver

Wu X, Shen Q, Xie X, Chen Y, Liang B, Wang M, et al. Genetic Evaluation and Pregnancy Outcomes in Foetuses With Overgrowth at a Tertiary Referral Center. Journal of Cellular and Molecular Medicine. 2026;30(14). doi:10.1111/jcmm.71162

BibTeX
@article{Wu2026,
  author = {Wu, Xiaoqing and Shen, Qingmei and Xie, Xiaorui and Chen, Yuqin and Liang, Bin and Wang, Meiying and Guo, Danhua and Lin, Na and Xu, Liangpu},
  title = {Genetic Evaluation and Pregnancy Outcomes in Foetuses With Overgrowth at a Tertiary Referral Center},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {14},
  doi = {10.1111/jcmm.71162}
}
Kostenlos starten →